Glaucoma management is shifting toward earlier, drop-sparing interventions using sustained drug delivery and advanced laser ...

Biotechnology company Optigo Biotherapeutics received the People’s Choice Award at the 2025 Eyecelerator meeting for the ...

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic ...

Beacon Therapeutics reveals promising interim results for laru-zova, a gene therapy showing potential to improve vision in ...